Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
08/03/1995 | CA2181376A1 Aralkylamino substituted azacyclic therapeutic agents |
08/03/1995 | CA2180528A1 Inhibitors of geranylgeranyl-protein transferase |
08/03/1995 | CA2179715A1 Use of vanadium molybdenum or tungsten complexes for controlling cellular proliferation |
08/02/1995 | EP0664780A1 10-substituted 1,8-dihydroxy-9(10h) anthracenone pharmaceuticals |
08/02/1995 | EP0664711A1 Peptide inhibitors of cellular adhesion |
08/02/1995 | EP0664706A1 Protein kinase c inhibition and novel compound balanol |
08/02/1995 | EP0664700A1 Treatment of cachexia and inhibition of il-6 activity |
08/02/1995 | EP0664695A1 Method and composition for treating muco-epidermal and epidermal pain, inflammation and infection |
08/02/1995 | CN1105993A Preparation of sustituted azole |
08/02/1995 | CN1105991A Quinoline compounds |
08/01/1995 | US5438141 Heteroaryl and haloaryl quinoline derivatives of cyclopropaneacetic acid as leukotriene antagonists |
08/01/1995 | US5438067 Medetomidine preparations for transdermal administration |
08/01/1995 | CA1336516C Acyl derivatives of 2-amino-4-substituted-5-hydroxy pyrimidines |
07/27/1995 | WO1995019978A1 Tetracyclic derivatives, process of preparation and use |
07/27/1995 | WO1995019970A1 Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
07/27/1995 | WO1995019965A1 Synthetic matrix metalloprotease inhibitors and uses thereof |
07/27/1995 | WO1995019961A1 Metalloproteinase inhibitors |
07/27/1995 | WO1995019959A1 Amino acid derivatives and their use as phospholipase a2 inhibitors |
07/27/1995 | WO1995019957A1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
07/27/1995 | WO1995019956A1 Metalloproteinase inhibitors |
07/27/1995 | WO1995019790A1 Humanized antibodies against leukocyte adhesion molecule vla-4 |
07/27/1995 | WO1995019774A1 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
07/27/1995 | WO1995019767A1 Guanylhydrazones for treating inflammatory conditions |
07/27/1995 | CA2181709A1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
07/27/1995 | CA2177372A1 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
07/27/1995 | CA2158760A1 Synthetic matrix metalloprotease inhibitors and uses thereof |
07/27/1995 | CA2126361A1 Gene encoding cationic amino acid transporter protein |
07/26/1995 | EP0664289A2 Isoquinolines |
07/26/1995 | EP0664282A1 Biaryl phospholipase A2 inhibitors |
07/26/1995 | EP0664127A2 Pharmaceutical compositions containing isoquinoline derivatives |
07/26/1995 | EP0664125A1 Inhibition of myeloperoxidase activity |
07/26/1995 | EP0663919A1 Pyrimidine bisphosphonate esters as anti-inflamatories |
07/26/1995 | EP0663918A1 Pure enantiomers of phosphoric-acid esters as phospholipase-a2 inhibitors |
07/26/1995 | EP0663916A1 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants |
07/26/1995 | EP0663839A1 Ibuprofen-h 2? antagonist combinations |
07/26/1995 | EP0663819A1 Ibuprofen-caffeine combinations |
07/26/1995 | EP0502092B1 Oral composition for the treatment of inflammatory bowel diseases |
07/26/1995 | EP0416037B1 Superoxide dismutase analogs having novel binding properties |
07/25/1995 | US5436401 Skin disorders |
07/25/1995 | US5436369 Alicyclic phospholipase A2 inhibitors |
07/25/1995 | US5436321 Antibodies to the lipopolysaccharide bonding opsonin septin |
07/25/1995 | US5436258 Prevention of bone resorption |
07/25/1995 | US5436247 Antiinflammatory agents or antiarthritic agents |
07/25/1995 | US5436241 Topical anti-inflammatory compositions containing piroxicam |
07/25/1995 | US5436233 Nervous system disorders |
07/25/1995 | US5436162 Human manganese superoxide dismutase (hMn-SOD) |
07/25/1995 | US5436154 Stable hybridoma cells and antigen-antibodies |
07/25/1995 | CA1336431C Thiazolo(5,4-b)azepine compounds |
07/20/1995 | WO1995019436A1 Mammalian monocyte chemoattractant protein receptors |
07/20/1995 | WO1995019372A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
07/20/1995 | WO1995019362A1 Dihydro pyrazolopyrroles |
07/20/1995 | WO1995019356A1 Endopeptidase 24.15 inhibitor |
07/20/1995 | WO1995019344A1 Gem-disubstituted azacyclic tachykinin antagonists |
07/20/1995 | CA2180746A1 Gem-disubstituted azacyclic tachykinin antagonists |
07/19/1995 | EP0663393A1 Novel 3-amino/hydroxy-4- 4-benzoylphenylcarboxylamino/oxy -azepanes and their homologies as protein kinase inhibitors |
07/19/1995 | EP0662957A1 1,4-disubstituted piperazines useful in the therapy of the asthma and of the inflammation of the respiratory tract |
07/19/1995 | EP0662840A1 Pharmaceutical compositions and methods for treating cold symptoms |
07/19/1995 | EP0662838A1 Method of treating rheumatoid arthritis with type ii collagen |
07/19/1995 | EP0662834A1 Novel epoxide-containing compounds |
07/19/1995 | EP0662831A1 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions |
07/19/1995 | EP0662782A1 Pp14-based therapy |
07/19/1995 | CN1105368A Corticosteroid 17-alkyl carbonate 21-|O¨-carboxylic and carbonic esters, processes for their preparation, and pharmaceuticals containing these compounds |
07/19/1995 | CN1105363A Quinoline or quinazoline derivatives, their production and use |
07/18/1995 | US5434248 Peptidyl derivatives as inhibitors of interleukin-1β converting enzyme |
07/18/1995 | US5434186 Antiinflammatory agents |
07/18/1995 | US5434183 Phospholipids containing omega-3-fatty acids |
07/18/1995 | US5434178 1,3,5 trisubstituted pyrazole compounds for treatment of inflammation |
07/18/1995 | US5434160 Autoimmune diseases; prevention of excess cell proliferation or enzyme release |
07/18/1995 | US5434158 Asthma |
07/18/1995 | US5434151 Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
07/18/1995 | US5434150 Anticoagulants, cardiovascular disorders |
07/18/1995 | US5434149 Phosphodiesterase inhibitors |
07/18/1995 | US5434131 Chimeric CTLA4 receptor and methods for its use |
07/18/1995 | US5433940 Synthetic molecules mimic action of hirudin by binding to both the low affinity anion-binding exosite and the catalytic site of thrombin |
07/18/1995 | CA1336349C Nitrogenous polycyclic tripeptides, their preparation and pharmaceutical compositions containing them |
07/18/1995 | CA1336323C Process for the preparation of anti-inflammatory pharmaceutical agents with an ibuprofen base, with elimination, in solution, of the bitter taste, burning of the throat and intestinal toxicity |
07/13/1995 | WO1995018826A2 Purified primate ctla-8 antigens and related reagents |
07/13/1995 | WO1995018820A1 Monomeric diols and phosphate linked oligomers formed therefrom |
07/13/1995 | WO1995018819A1 Ligand that binds fas antigen |
07/13/1995 | WO1995018799A1 Phenyl heterocycles as cox-2 inhibitors |
07/13/1995 | WO1995018797A1 Novel serine protease inhibitors: derivatives of isothiazolidin-3-one-1,1 dioxide and 3-oxo-1,2,5-thiadiazolidine-1,1-dioxide |
07/13/1995 | WO1995018793A1 Novel heterocyclic compounds |
07/13/1995 | WO1995018792A1 Pyrrolidine-containing monomers and oligomers |
07/13/1995 | WO1995018620A1 Treatment using arachidonic acid metabolite and particulate formulations |
07/13/1995 | WO1995018615A1 A method of treating neurogenic inflammation |
07/13/1995 | WO1995018610A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
07/13/1995 | CA2180651A1 Phenyl heterocycles as cox-2 inhibitors |
07/13/1995 | CA2180239A1 A method of treating neurogenic inflammation |
07/13/1995 | CA2180238A1 Novel heterocyclic compounds |
07/13/1995 | CA2180123A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
07/13/1995 | CA2179986A1 Treatment using arachidonic acid metabolite and particulate formulations |
07/13/1995 | CA2179913A1 Novel serine protease inhibitors: derivatives of isothiazolidin-3-one-1,1 dioxide and 3-oxo-1,2,5-thiadiazolidine-1,1-dioxide |
07/13/1995 | CA2139391A1 Azepanes and homologs thereof |
07/12/1995 | EP0662148A1 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor |
07/12/1995 | EP0662003A1 Oligonucleotide modulation of cell adhesion |
07/12/1995 | EP0661996A1 Mhc subunit conjugates useful in ameliorating deleterious immune responses |
07/12/1995 | EP0661992A1 Pharmaceutical formulations of interleukin-1 inhibitors |
07/12/1995 | EP0661978A1 Arylmethylphosphonates and phosphonic acids useful as anti-inflammatory agents |
07/12/1995 | CN1105016A Triglycerides |
07/11/1995 | US5432181 Substituted heteroaryl analogs of 4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |